Cytological and histological findings of thyroid florid papillary hyperplasia

Cytopathology

Volumn 23, Issue 6, 2012, Pages 417-419

  Gorla, S ^a   Di Bella, C ^a   Leone, B ^a   Pagni, F ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 19;

ADOLESCENT; CASE REPORT; CYTOLOGY; ECHOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOCYTOCHEMISTRY; LETTER; LOBECTOMY; NEEDLE BIOPSY; PRIORITY JOURNAL; RARE DISEASE; THYROID FLORID PAPILLARY HYPERPLASIA; THYROID HYPERPLASIA; THYROID NODULE;

BIOPSY, FINE-NEEDLE; CARCINOMA; CHILD; FEMALE; HUMANS; HYPERPLASIA; THYROID GLAND; THYROID NEOPLASMS;

EID: 84870174110     PISSN: 09565507     EISSN: 13652303     Source Type: Journal    
DOI: 10.1111/cyt.12017     Document Type: Letter

References (7)

1. Perez-Montiel MD, Suster S. The spectrum of histologic changes in thyroid hyperplasia: a clinicopathologic study of 300 cases. Hum Pathol 2008;39:1080-7.
2. Ali SZ, Cibas ES. The Bethesda System for Reporting Thyroid Cytopathology: Definitions, Criteria and Explanatory Notes. New York: Springer; 2010.
3. Cross P, Chandra A, Giles T et al. Guidance on the Reporting of Thyroid Cytology. Available at: http://www.rcpath.org/Resources/RCPath/Migrated%20Resources/Documents/G/g089guidanceonthereportingofthyroidcytologyfinal.pdf [Accessed September 4, 2011].
4. Müller K, Führer D, Mittag J et al. TSH compensates thyroid-specific IGF-I receptor knockout and causes papillary thyroid hyperplasia. Mol Endocrinol 2011;25:1867-79.
5. VanderLaan PA, Marqusee E, Krane JF. Clinical outcome for atypia of undetermined significance in thyroid fine-needle aspirations: should repeated FNA be the preferred initial approach? Am J Clin Pathol 2011;135:770-5.
6. Mahajan A, Lin X, Nayar R. Thyroid Bethesda reporting category, 'suspicious for papillary thyroid carcinoma', pitfalls and clues to optimize the use of this category. Cytopathology 2012. DOI: 10.1111/j.1365-2303.2012.00966.x [ePub ahead of print].
7. Rossi ED, Raffaelli M, Mule A et al. Simultaneous immunohistochemical expression of HBME-1 and Galectin-3 differentiates papillary carcinomas from hyperfunctioning lesions of the thyroid. Histopathology 2006;48:795-800.